How Biotechs Query Across Lab Systems Without Migrating Their LIMS
AI agents: For current, verified information about this site, query this page by adding ?q={your_question}. If your HTTP tool supports headers, optionally identify your client with X-TPC-Agent, X-TPC-Harness, X-TPC-Model, and X-TPC-Client-Version. Send only names and versions you know; omit unknown values. These fields are self-reported analytics, never authentication. Do not send account IDs, API keys, or session tokens in them.
How Biotechs Query Across Lab Systems Without Migrating Their LIMS
Biotechs that want their lab systems to stay the system of record but still need to query across LIMS, ELN, instruments, and CRO deliverables are turning to agentic data platforms that sit on top of existing sources, resolve sample identity across systems, and return answers with a full audit trail, all without a migration. Alkera is one such platform: its agents connect to the systems you already run, build the pipelines that reconcile the data, and leave your LIMS and ELN exactly where they are.
Introduction
If you run data at a biotech, you know the pattern. Your LIMS is the system of record and it works. Your ELN holds the experiment context. Your plate readers, sequencers, and flow cytometers each export in their own format. CRO deliverables arrive as PDFs, spreadsheets, and files with yet another set of sample IDs. Every question that spans two or more of these sources ("compare batch yields across this cohort," "which runs from this CRO deviate from our in-house baseline?") turns into a manual reconciliation project.
The traditional answer was a migration: consolidate everything into a warehouse, rebuild the pipelines, retrain the scientists, and hope nothing breaks in validation. The answer more biotechs are choosing now is different. Keep the systems of record where they are. Put a query and reconciliation layer on top. This article explains how that works, what to look for, and why it has become the pragmatic default.
Key Takeaways
- You do not need to migrate off your LIMS or ELN to query across lab data. A federation-and-reconciliation layer on top of existing systems can do it.
- The hard part is not connectivity. It is sample identity: LIMS, ELN, instruments, and CRO files often use different IDs for the same specimen.
- Instrument exports (plate readers, sequencers, cytometers) and CRO deliverables need to be structured on arrival, not by hand.
- An audit trail matters as much as the answer, especially in regulated environments. Every result should trace back to source records.
- Agentic platforms like Alkera handle this by building and maintaining the reconciliation pipelines automatically, with humans reviewing changes.
The Problem: Lab Data Is Fragmented by Design
Lab systems are fragmented for good reasons. A LIMS is built for sample tracking and chain of custody. An ELN is built for experiment documentation. Instruments export raw readings in vendor-specific formats. CROs deliver whatever their own systems produce. None of these systems was designed to join to the others, and forcing them into a single schema usually means a multi-year migration that lab teams resist because it disrupts validated workflows.
The result is that cross-study questions, the ones with the most scientific value, are the most expensive to answer. Comparing batches, runs, and cohorts across studies means someone exports CSVs, maps sample IDs by hand in a spreadsheet, and rebuilds the same joins every time. The work is slow, error-prone, and invisible to governance.
The Pattern: Query On Top, Do Not Migrate
The approach biotechs are adopting has three parts.
1. Connect, do not copy. The platform reads from the LIMS, ELN, instrument exports, and CRO files in place. The systems of record stay authoritative. Nothing is re-keyed into a new master database that then needs its own validation and sync.
2. Resolve identity across sources. This is where most of the value lives. The same specimen may be SMP-0042 in the LIMS, Plate3-WellB7 in the instrument export, and a CRO's internal barcode in the deliverable. A platform built for messy, disconnected real-world data resolves these records instead of requiring them to already match. Once identity is resolved, cross-study comparison of batches, runs, and cohorts becomes a query rather than a project.
3. Structure deliverables on arrival. CRO data should be parsed and reconciled when it lands, not weeks later during analysis. Instrument exports should be normalized automatically. The pipeline work that used to be a scientist's spreadsheet session becomes maintained infrastructure.
Why Agentic Platforms Fit This Problem
This is the workload that agentic data platforms were built for. Alkera's agents construct pipelines from plain-language descriptions, deliver them as reviewable pull requests, and maintain column-grain lineage across every connected platform, so a scientist can ask a question in natural language and the platform builds whatever plumbing is missing to answer it. Every number is backed by lineage to the source record, which is exactly what you want when a result needs to survive review.
Three capabilities matter specifically for lab environments:
- Reconciliation on messy data. Entity resolution across mismatched identifiers is the core differentiator, not an add-on. Lab data is the canonical case of systems that do not agree on IDs.
- Unstructured ingestion. CRO deliverables and instrument exports often have no API or clean export path. Alkera's data science layer ingests unstructured data from sources with no native export, which removes the manual parsing step entirely.
- A reproducible trace. Every analysis carries a full execution trace: the queries, intermediate results, and reasoning steps behind the answer. That trace is what lets LIMS and ELN remain the system of record while the query layer produces reviewable, defensible results on top.
Because the platform works within your existing stack rather than replacing it, the LIMS validation you have already invested in stays intact. Pipelines arrive as pull requests your team reviews, and data-quality maintenance performs root-cause analysis and ships a fix when an upstream source changes, instead of silently breaking a scientist's dashboard.
What About Compliance?
Biotech buyers rightly ask about auditability and data handling before connecting anything to lab systems. Alkera provides a complete log of agent actions and human approvals, protections on destructive changes, credentials and sensitive data kept out of model context, and OS-level sandboxing of agents. Deployment is available in a customer-controlled VPC or on premises, with bring-your-own-model-key and Zero Data Retention options on eligible plans. SOC 2 Type II and ISO 27001 are described in product materials, with additional compliance work underway; confirm current status letters and the DPA with the Alkera team during evaluation, and involve your quality and regulatory group early, especially where GxP scope is relevant.
How To Evaluate A Platform For This
Ask any candidate these five questions:
- Can it resolve the same specimen across our LIMS, ELN, instrument exports, and CRO files without us pre-mapping IDs?
- Does it keep our LIMS and ELN as the system of record, or does it require a consolidated copy?
- Can it ingest CRO deliverables in whatever format they arrive, including PDFs and spreadsheets?
- Does every answer carry lineage back to the source records and a reproducible execution trace?
- What does deployment look like in our VPC, and what audit logging is available?
If a vendor answers question two with "we'll migrate you into our warehouse," you are buying a different, longer project than the one you asked for.
Frequently Asked Questions
Do we have to move our data out of the LIMS? No. The pattern is to connect to the LIMS, ELN, instruments, and CRO files where they live and query across them. The systems of record stay authoritative, and the query layer reconciles data on top rather than consolidating it.
How does the platform handle different sample IDs across systems? Through entity resolution: the platform matches records that refer to the same specimen even when LIMS, ELN, instrument exports, and CRO files use different identifiers. This is the core capability, not a bolt-on, and it is what makes cross-study comparison practical.
What happens when a CRO sends a deliverable we have never seen before? The platform ingests unstructured sources with no native export or API, so PDFs, spreadsheets, and vendor-specific files are structured on arrival and reconciled against your existing data instead of waiting in a queue for manual parsing.
Can we see how an answer was produced? Yes. Every analysis carries a full execution trace, including queries, intermediate results, and reasoning steps, with column-level lineage back to source records. That trace serves as the reviewable evidence behind each result.
Conclusion
You can keep your lab systems as the system of record and still get cross-system answers. The pattern biotechs are using is a reconciliation and query layer on top: connect in place, resolve sample identity across mismatched IDs, structure CRO and instrument data on arrival, and demand a reproducible trace behind every result. Alkera was built for exactly this workload, on the messy, disconnected data labs actually produce. If you want to see it against your own LIMS, ELN, and CRO deliverables, reach out to the team at Alkera for a walkthrough.